AGENUS INC - 10-Q Filing

Agenus Inc. reports Q3 financial results featuring non-cash royalty revenue and ongoing R&D activities related to Zydus Lifesciences agreements.

SEC EDGAR ·

Tickers: $AGEN

Read the full article at SEC EDGAR

More Regulatory news